While the Fed appears to be floating the idea of buying equities in the future, two experts say they have concerns about such a plan. » Read More
European bank stocks finished the quarter up on Friday, making it the index's best quarter since the first quarter of 2015.
Biotech stocks have been taking a beating, and traders see especially bad things ahead for one company.
CNBC Pro highlights the top-performing stocks this week and analyzes whether the good times will continue.
Todd Gordon of TradingAnalysis.com shorts the IWM, the ETF tracking small-cap stocks.
Shares of Deutsche Bank were leaping in New York trade Friday, but there's reason to be skeptical about a settlement being cited.
Chris Whalen said Friday statements made by politicians are responsible for the global market panic centered around Deutsche Bank.
Nutanix is the biggest venture-backed tech company to debut in the U.S. this year, and there are many risks attached.
This big move out of Deutsche Bank may not threaten the bank, but it does tell you what the market thinks of Europe right now.
Venture capitalist Marc Andreessen says valuations are a little high, but a pullback could lead to more M&A activity.
Fundstrat's Tom Lee recommends investors buy technology stocks into year-end.
The concerns around Deutsche Bank are about profitability not bankruptcy, says Axiom's David Benamou, whose firm is short the stock.
Despite its current challenges, Deutsche Bank is not as far off the proverbial deep end as current speculation suggests, Morgan Creek's Mark Yusko tells CNBC.
Options pro Andrew Keene makes the case for putting on a high-payoff trade on e-commerce giant Alibaba.
The high-flying stock price put the Nutanix IPO on pace for the best debut of the year.
Cramer says Deutsche Bank won't pay the $14 billion settlement due to the friendship between President Barack Obama and Angela Merkel.
Wall Street firms are cautiously defending Deutsche Bank's liquidity position.
Get the best of CNBC in your inbox